DK0491094T3 - Felbamat til behandling af Lennox-Gastaut-syndromet - Google Patents

Felbamat til behandling af Lennox-Gastaut-syndromet

Info

Publication number
DK0491094T3
DK0491094T3 DK90313735.4T DK90313735T DK0491094T3 DK 0491094 T3 DK0491094 T3 DK 0491094T3 DK 90313735 T DK90313735 T DK 90313735T DK 0491094 T3 DK0491094 T3 DK 0491094T3
Authority
DK
Denmark
Prior art keywords
felbamate
lennox
treatment
gastaut syndrome
gastaut
Prior art date
Application number
DK90313735.4T
Other languages
English (en)
Inventor
Robert Duane Sofia
Original Assignee
Carter Wallace
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carter Wallace filed Critical Carter Wallace
Application granted granted Critical
Publication of DK0491094T3 publication Critical patent/DK0491094T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90313735.4T 1989-09-26 1990-12-17 Felbamat til behandling af Lennox-Gastaut-syndromet DK0491094T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/412,964 US4978680A (en) 1989-09-26 1989-09-26 Method for the prevention and control of epileptic seizure

Publications (1)

Publication Number Publication Date
DK0491094T3 true DK0491094T3 (da) 1996-11-11

Family

ID=23635221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90313735.4T DK0491094T3 (da) 1989-09-26 1990-12-17 Felbamat til behandling af Lennox-Gastaut-syndromet

Country Status (7)

Country Link
US (1) US4978680A (da)
EP (1) EP0491094B1 (da)
AT (1) ATE142492T1 (da)
DE (1) DE69028542T2 (da)
DK (1) DK0491094T3 (da)
ES (1) ES2094145T3 (da)
GR (1) GR3021801T3 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055489A (en) * 1990-05-04 1991-10-08 Carter-Wallace, Inc. Method for the prevention and control of hypoxic damage resulting from cerebral ischemic events
DE69219039T2 (de) * 1991-09-03 1997-07-24 Carter Wallace Verwendung von Felbamate zur Herstellung eines Arzneimittels zur Behandlung neuropsychopharmakologischer Störungen
US5290808A (en) * 1992-11-06 1994-03-01 Carter-Wallace, Inc. Method to control the intake of food
US5462966A (en) * 1993-10-15 1995-10-31 Carter-Wallace Inc. Methods for the prevention and control of cellular damage resulting from coronary artery occlusion-reperfusion
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5728728A (en) * 1996-04-10 1998-03-17 Kozachuk; Walter E. Methods of providing neuroprotection
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US7277758B2 (en) 1998-08-05 2007-10-02 Neurovista Corporation Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7324851B1 (en) 1998-08-05 2008-01-29 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US9320900B2 (en) 1998-08-05 2016-04-26 Cyberonics, Inc. Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US7403820B2 (en) 1998-08-05 2008-07-22 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
WO2000047202A1 (en) 1999-02-09 2000-08-17 University Of Virginia Patent Foundation Felbamate derived compounds
CA2427058A1 (en) * 2000-10-25 2002-07-25 University Of Virginia Patent Foundation Substituted felbamate derived compounds
US20030166648A1 (en) * 2002-11-01 2003-09-04 Macdonald Timothy L Felbamate derived compounds
WO2006116007A2 (en) * 2005-04-21 2006-11-02 Medpointe Healthcare Inc. Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US20080027348A1 (en) 2006-06-23 2008-01-31 Neuro Vista Corporation Minimally Invasive Monitoring Systems for Monitoring a Patient's Propensity for a Neurological Event
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US20080183097A1 (en) * 2007-01-25 2008-07-31 Leyde Kent W Methods and Systems for Measuring a Subject's Susceptibility to a Seizure
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US7884227B2 (en) * 2007-10-26 2011-02-08 Navinta Llc Felbamate with improved bulk density
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US20090171168A1 (en) 2007-12-28 2009-07-02 Leyde Kent W Systems and Method for Recording Clinical Manifestations of a Seizure
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US9233898B2 (en) 2010-09-07 2016-01-12 Taro Pharmaceutical Industries Ltd. Process for the preparation of 2-phenyl-1,3-propanediol

Also Published As

Publication number Publication date
EP0491094A1 (en) 1992-06-24
US4978680A (en) 1990-12-18
EP0491094B1 (en) 1996-09-11
ATE142492T1 (de) 1996-09-15
ES2094145T3 (es) 1997-01-16
GR3021801T3 (en) 1997-02-28
DE69028542T2 (de) 1997-02-06
DE69028542D1 (de) 1996-10-17

Similar Documents

Publication Publication Date Title
DK0491094T3 (da) Felbamat til behandling af Lennox-Gastaut-syndromet
DK0654264T3 (da) Anvendelse af venlafaxin eller en aryloxypropanaminforbindelse til fremstilling af et lægemiddel til behandling af urininkontinens
BR9000416A (pt) Catalisadores para polimerizacao de olefinas
ATE102470T1 (de) Absorbierendes material.
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
DK669088A (da) Fremgangsmaade og praeparat til forbedring af erkendelsesfunktionen
BR9107049A (pt) Aril-haloquirazois substituidos herbicidas
DE3382437D1 (de) Pyrazolesulfonylharnstoff-derivate, ihre herstellung, herbizide das diese derivate als wirkstoffe enthaelt und herbizides verfahren damit.
DE3768052D1 (de) Optisch aktive adsorbentien.
DK0696937T3 (da) Fremgangsmåde til behandling af spontant forbrændelige katalysatorer
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DK0662837T3 (da) Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
ES522555A0 (es) Procedimiento para el tratamiento de un reactor de polimerizacion.
AR230053A1 (es) Un procedimiento para la preparacion de un compuesto racemico u opticamente activo de oxazolidina-2.4-diona 5-sustituida y compuesto intermediario para el mismo
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
FI865050A0 (fi) Belaeggningsmassa foer elastiska underlag, dess anvaendning och foerfarande foer framstaellning av skyddsbelaeggningar.
NO901622L (no) Termoplastiske akryliske elastomerer.
FI852061A0 (fi) Plast med stor uv-permeabilitet, och foerfarande foer dess framstaellning.
FI893107A (fi) Ett nytt aemne baserat pao bornitrit, dess framstaellningsfoerfarande och anvaendning som foerstaerkning.
DK0430035T3 (da) Anvendelse af benzothiazepiner til fremstilling af lægemidler til behandling af epileptiske anfald
DE68913866D1 (de) Ablaufschacht, Destillationsbodenanordnung und Destillationskolonne.
DK301190A (da) Bioforenelige, stof-specifikke reagenser til behandling af fysiologiske vaesker
DE58908686D1 (de) Lederbehandlungsmittel.
ATE81002T1 (de) Fixe arzneimittelkombination mit verzoegerter freisetzung.